← Evidence map

TrialIn vivo (Athens, Greece)

Bevacizumab and Atezolizumab for Unresectable Hepatocellular Carcinoma: Real-world Data in Taiwan-Tainan Medical Oncology Group H01 Trial.

Yang-Cheng Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

13 papers cite it

2023
2024
2025
2026
cites it
Full record →Abstract, authors, funding and every citing paper · PMID 36593061